BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 1430254)

  • 1. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on CFU-Mix in 54 cases of leukemia and myelodysplastic syndrome].
    Chen Y; Wang BM; Li CY
    Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):35-8, 62-3. PubMed ID: 2737036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
    Rosati S; Anastasi J; Vardiman J
    Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
    [No Abstract]   [Full Text] [Related]  

  • 5. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
    Soligo D; Delia D; Oriani A; Cattoretti G; Orazi A; Bertolli V; Quirici N; Deliliers GL
    Leukemia; 1991 Dec; 5(12):1026-30. PubMed ID: 1723130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of bone marrow reconstitution after allogeneic bone marrow transplantation.
    van den berg H; Kluin PM; Zwaan FE; Vossen JM
    Histopathology; 1989 Oct; 15(4):363-73. PubMed ID: 2807194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural characteristics of bone marrow in patients with hematological disease: a study of 13 cases.
    Ru YX; Zhao SX; Liu EB; Yang QY; Liu JH; Pang TX; Chen HS
    Ultrastruct Pathol; 2007; 31(5):327-32. PubMed ID: 17963181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
    Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
    Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
    Tuzuner N; Cox C; Rowe JM; Bennett JM
    Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. General Haematology Task Force of the BCSH.
    Clin Lab Haematol; 1996 Dec; 18(4):231-6. PubMed ID: 9054693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cells and hematopoiesis: a light microscopic study of fetal, normal, and pathologic human bone marrow in plastic-embedded sections.
    Islam A; Glomski C; Henderson ES
    Anat Rec; 1992 Jul; 233(3):440-52. PubMed ID: 1609975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histology of bone marrow in acute leukaemia.
    Dominis M; Dzebro S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():10-1. PubMed ID: 2627593
    [No Abstract]   [Full Text] [Related]  

  • 15. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harlequin cell: Ubiquitous or pathognomic?
    Jain G; Kumar C; Chopra A
    Int J Lab Hematol; 2020 Apr; 42(2):e42-e44. PubMed ID: 31424608
    [No Abstract]   [Full Text] [Related]  

  • 17. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
    Nakase K; Kita K; Kyo T; Katayama N
    Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia.
    de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A
    Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713
    [No Abstract]   [Full Text] [Related]  

  • 20. Stromal abnormalities in neoplastic bone marrow diseases.
    Dührsen U; Hossfeld DK
    Ann Hematol; 1996 Aug; 73(2):53-70. PubMed ID: 8774614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.